Cancer

The FDA has granted accelerated approval to AstraZeneca drug Etcamah for certain adults with advanced breast cancer carrying an ESR1 mutation. Etcamah, also known as camizestrant, was approved in combination with a CDK4/6 inhibitor, either abemaciclib, palbociclib or ribociclib. The treatment is for adults with hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer when [...]

Scotland has launched a review of NHS IVF access, including whether treatment should extend to single women and couples with children from previous relationships. The national review will assess how fertility services can better reflect modern family structures while maintaining fair and consistent access across Scotland. It will also examine access to fertility preservation services, [...]

Women’s health medical device company Ark Surgical has secured further institutional backing from JNF and the Israel Innovation Authority (IIA) as it accelerates the US commercial expansion of its surgical tissue containment technology. Both organisations have previously backed Ark, making the renewed support a significant vote of confidence in the company’s technology, leadership team and [...]

AI may help detect heart disease in women from routine mammograms, according to research involving almost 30,000 women. Researchers found a machine-learning model could distinguish women with coronary heart disease, high blood pressure or a previous stroke using mammogram images. The findings suggest breast cancer screening could potentially also flag cardiovascular problems without requiring an [...]

Nearly a third of women aged 21 to 29 have never been screened for cervical cancer, according to research tracking screening trends over 20 years. The proportion of women in their 20s who reported never being screened for cervical cancer has increased over the past two decades. Among women aged 30 to 64, almost 15 [...]

A French court has linked cosmic radiation to a former flight attendant's breast cancer for the first time. Sophie Lainault, 59, had sought to have her cancer recognised as an occupational disease linked to her working conditions. The court in Bayonne ruled that cosmic radiation was one of three carcinogenic, or cancer-causing, hazards arising from [...]

Breast cancer has more molecularly targeted options than any other tumour in women's health. The evidence now shows that the limiting factor is no longer the drug, and no longer the science. It is the test - and the decision it is supposed to inform. By Wolfgang Hackl, MD, OncoGenomX A paradox worth sitting with [...]

Millions of women who have missed cervical screening in England will be offered free NHS home HPV tests. The initiative is aimed at women who are not up to date with screening, with NHS estimates suggesting as many as 4 million have fallen behind. The home kits contain a swab for collecting a vaginal sample, [...]

A drug targeting a key regulator in triple-negative breast cancer reduced tumour growth and cancer stem cell viability in laboratory models. Triple-negative breast cancer is an aggressive subtype that disproportionately affects women under 40 and accounts for about 15 to 20 per cent of breast cancers. The disease lacks receptors for oestrogen, progesterone and the [...]

Australia's drug advisory committee has recommended wider funding of triptorelin for women with breast cancer or endometriosis. The recommendation comes after AstraZeneca announced plans to remove Zoladex from the market, risking leaving more than 7,500 women with breast cancer without an alternative treatment. Both medicines block the release of oestrogen and testosterone and can be [...]